Epileptic Intermittent Snoring
Neurol 56:1601-1602, Rubboli,G.,et al, 2001
Acute Stroke Patterns in Patients With Internal Carotid Artery Disease
Stroke 32:1323-1329, Szabo,K.,et al, 2001
Pallidal Stimulation for Generalized Dystonia
J Neurosurg 92:453-456, Tronnier,V.M. &Fogel,W., 2000
Progressive Forms of MS:Classification Streamlined or Consensus Overturned?
Lancet 355:162-163, Weinshenker,B.G., 2000
A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000
Prevalence of Nonconvulsive Status Epilepticus in Comatose Patients
Neurol 54:340-345, Towne,A.R.,et al, 2000
Glatiramer Acetate (Copaxone) Treatment in Relapsing-Remitting MS
Neurol 54:813-817, Ge,Y.,et al, 2000
Psychogenic Status Epilepticus in Children: Psychiatric and Other Risk Factors
Neurol 54:969-970, Pakalnis,A.,et al, 2000
Primary Neurosarcoidosis:A Diagnostic and Therapeutic Challenge
The Neurologist 6:126-133, Nikhar,N.K.,et al, 2000
Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000
Pseudoulnar Palsy From a Small Infarct of the Precentral Knob
Neurol 54:2185, Phan,T.G.,et al, 2000
West Nile Viral Encephalitis in an HIV-Positive Woman in New York
NEJM 342:59-60, Szilak,I.&Minamoto,G.Y., 2000
Axial Parkinsonian Symptoms Can Be Improved: The Role of Levodopa and Bilateral Subthalamic Stimulation
JNNP 68:595-600, Bejjani,B.P.,et al, 2000
How Well Does the Oxfordshire Community Stroke Project Classification Predict the Site and Size of the Infarct on Brain Imaging
JNNP 68:558-562,547, Mead,G.E.,et al, 2000
Motor Strokes Sparing the Leg
Arch Neurol 57:513-518, de Freitas,G.R.,et al, 2000
Cerebrospinal Fluid Oligoclonal IgG Bands in Patients With Spinal Arteriovenous Malformation and Structural Central Nervous System Lesions
Arch Neurol 57:553-557, Cohen,O.,et al, 2000
Misdiagnosis of Epilepsy: Many Seizure-Like Attacks Have a Cardiovascular Cause
J Am Coll Cardiol 36:181-184, Zaidi,A. et al, 2000
Reversible Tacrolimus-Induced Neurotoxicity Isolated to the Brain Stem
AJNR 21:1251-1254, Oliverio,P.J. et al, 2000
Retrospective Analysis of the Use of Cyclosporine in Myasthenia Gravis
Neurol 55:448-450, Ciafaloni,E. et al, 2000
Multiple Sclerosis--From Probable to Definite Diagnosis
Arch Neurol 57:974-979,930, Achiron,A. & Barak,Y., 2000
Deep Brain Stimulation of Subthalamic Area for Severe Proximal Tremor
Neurol 55:114-116, Kitagawa,M. et al, 2000
Psychological Stress and the Subsequent Appearance of New Brain MRI Lesions in MS
Neurol 55:55-61, Mohr,D.C. et al, 2000
Cerebrovascular Monitoring During Carotid Endarterectomy
Stroke 31:1799-1801, Babikian,V.L. & Cantelmo,N.L., 2000
Surgery for Parkinson Disease
Arch Neurol 57:1118-1125, Lang,A.E., 2000
A Case of Balamuthia mandrillaris Meningoencephalitis
Arch Neurol 57:1210-1212, Katz,J.D. et al, 2000
Central Nervous System Aspergillosis in Patients with Human Immunodeficiency Virus Infection
Medicine 79:269-280, Mylonakis,E. et al, 2000
Current Clinical Diagnosis in Creutzfeldt-Jakob Disease; Identification of Uncommon Variants
Ann Neurol 48:323-329, Zerr,I. et al, 2000
Practice Parameter: Evaluating a First Nonfebrile Seizure in Children
Neurol 55:616-623, Hirtz,D. et al, 2000
Failure of Long-Term Pallidal Stimulation Corrected by Subthalmaic Stimulation in PD
Neurol 55:728-730, Houeto,J.L. et al, 2000
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
Analysis of EEG and CSF 14-3-3 proteins as adis to the diagnosis of Creutzfeldt-Jakob Disease
Neurol 55:811-815, Zerr,I. et al, 2000
Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000
Syncope
NEJM 343:1856-1862, Kapoor,W.N., 2000
Partial Seizures Presenting as Panic Attacks
BMJ 321:1002-1003, Thompson,S.A.,et al, 2000
Corpus Callosum Infarcts with Atypical Clinical and Radiologic Presentations
AJNR 21:1876-1880, Kasow,D.L.,et al, 2000
Distribution of Cranial MRI Abnormalities in Patients with Symptomatic and Subclinical CADASIL
BJR 73:256-265, Coulthard, A.,et al, 2000
Association of Primary Central Nervous System Lymphoma with Long-Term Azathioprine Therapy for Myasthenia Gravis?
Ann Neurol 47: 682-683, Herrlinger,U.,et al, 2000
Venous Infarcts
Neurol Neurochir Pol 34:937-946, Mendel,T., 2000
Progressive Multifocal Leukoencephalopathy and Idiopathic CD4+Lymphocytopenia:A Case Report and Review of Reported Cases
Clin Infect Dis 31:E20-22, Haider,S.,et al, 2000
Early Diagnosis of Central Nervous System Aspergillosis With Combination Use of Cerebral Diffusion-Weighted Echo-Planar Magnetic Resonance Image and Polymerase Chain Reaction of Cerebrospinal Fluid
Internal Medicine 38:45-48, Kami,M.,et al, 1999
Evaluation of Surgery for Parkinson's Disease, A Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 53:1910-1921, Hallett,M.,et al, 1999
Early Prognostic Indicators of Outcome in Infants with Neonatal Cerebral Infarction:A Clinical,Electroencephalogram,and Magnetic Resonance Imaging Study
Pediatrics 103:39-46, Mercuri,E.,et al, 1999
Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999
Course and Treatment of Myasthenia Gravis During Pregnancy
Neurol 52:447-452, Batocchi,A.P.,et al, 1999
Sensory Symptoms Restricted to Proximal Body Parts in Small Cortical Infarction
Neurol 53:889-890, Kim,J.S., 1999
Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999
Globus Pallidus Deep Brain Stimulation for Generalized Dystonia:Clinical and PET Investigation
Neurol 53:871-874, Kumar,R.,et al, 1999
Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999
The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999